WOCKPHARMAUpdated 4 Sept 2026, 3:16

Wockhardt Limited

WOCKPHARMAUpdated 4 Sept 2026, 3:16

Market Cap

₹31,696Cr.

Current Price

₹1,951

High / Low

₹2,422/1,087

Stock P/E

95.8

ROE9.99%

ROCE9.74%

Book Value₹190

Face Value₹5.00

Dividend Yield0.00%

About

Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments).[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	41	45	54	118	236	385	353	344	188	179	159	178
Inventory Days	240	216	206	141	195	367	305	297	330	254	357	469
Days Payable	158	134	133	167	325	611	355	446	507	459	398	442
Cash Conversion Cycle	123	126	127	92	105	141	303	194	11	-26	117	204
Working Capital Days	-223	-18	-73	-55	-52	-351	-334	-231	-404	-223	-7	72
ROCE %	20%	3%	9%	9%	-2%	-8%	-8%	2%	-1%	-4%	4%	10%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 4 September 2026 at 3:16

WOCKHARDT LIMITED (WOCKPHARMA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding